David Balat
April 18, 2023
Medicare Part B Meeting, 340B Implications
MedPAC, a group advising Congress on Medicare issues, held a vote on 3 recommendations to reduce prices for accelerated approval drugs covered under Medicare Part B; David Balat, Healthcare Policy Director for the Texas Publ…
None